Dr. Leen Kawas, Managing General Partner at Propel Bio Partners, highlights the myriad of ways in which a diverse management team can positively impact an entire workforce. In today’s increasingly global business landscape, workers with different nationalities and cultural profiles often come together to help achieve a company’s mission. Individuals…
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 4,820 shares of the business’s stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $2.91, for a total value of $14,026.20. Following the sale, the chief executive officer now directly owns 144,397 […]
Scinai Immunotherapeutics (NASDAQ:SCNI – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of […]